High-Purity (R)-1-[(4-Chlorophenyl)phenylmethyl]piperazine: A Key Intermediate for Levocetirizine Synthesis

(R)-1-[(4-Chlorophenyl)phenylmethyl]piperazine is a vital pharmaceutical intermediate, essential for the synthesis of the widely used antihistamine, levocetirizine. As a leading supplier in China, we offer high-purity material crucial for effective drug manufacturing.

Get a Quote & Sample

Advantages of Sourcing Our Pharmaceutical Intermediates

Exceptional Purity for API Synthesis

Our (R)-1-[(4-Chlorophenyl)phenylmethyl]piperazine meets stringent purity standards (≥98.0%), ensuring that your final levocetirizine product is safe and effective. Partner with us for your critical intermediate needs.

Cost-Effective Solutions from China

Leveraging advanced manufacturing capabilities, we offer competitive pricing for this key levocetirizine intermediate. Enquire about our bulk purchase options and get a quote for reliable supply.

Commitment to Quality and Stability

We ensure optimal storage conditions to maintain the integrity of our (R)-1-[(4-Chlorophenyl)phenylmethyl]piperazine, making it a dependable component in your synthesis workflow. Discover why we are a preferred supplier for this essential chemical.

Key Applications in Pharmaceutical Manufacturing

Levocetirizine Synthesis

This intermediate is indispensable for the production of levocetirizine, a highly effective antihistamine used globally for allergy relief. Reliable sourcing is key for manufacturers.

Chiral Drug Development

Its specific chirality is critical for the pharmacological activity of levocetirizine, making it a sought-after compound in chiral drug development and manufacturing.

Pharmaceutical Intermediate Supply

As a core building block, it supports the large-scale production of generic and branded levocetirizine formulations by pharmaceutical companies worldwide.

Research and Development

Researchers can buy this compound for early-stage drug discovery and process optimization related to antihistamines and other piperazine-based pharmaceuticals.